Valeo Financial Advisors LLC Acquires 57 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Valeo Financial Advisors LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,250 shares of the medical equipment provider’s stock after acquiring an additional 57 shares during the period. Valeo Financial Advisors LLC’s holdings in Intuitive Surgical were worth $2,105,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Atala Financial Inc bought a new position in Intuitive Surgical in the fourth quarter worth approximately $25,000. Chilton Capital Management LLC lifted its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares in the last quarter. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC boosted its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the period. Finally, Elite Financial Inc. bought a new position in Intuitive Surgical in the 1st quarter worth $26,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 1.4%

Shares of NASDAQ:ISRG opened at $527.30 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The company has a 50-day moving average price of $537.77 and a 200 day moving average price of $536.93. The company has a market cap of $188.99 billion, a price-to-earnings ratio of 77.32, a PEG ratio of 5.67 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the company posted $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Barclays dropped their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their target price for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $592.59.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.